Rapid Genomic Sequencing in NICU/PICU: Parents' Perspectives Explained (2026)

Experiencing acute genomic care: perspectives from parents in the neonatal and paediatric intensive care units towards rapid genomic sequencing

This study explores the experiences of parents whose newborns and children are in the neonatal and paediatric intensive care units (NICU/PICU) and are undergoing rapid genomic sequencing. The research aims to understand the perspectives of parents on the benefits, challenges, and ethical considerations of this technology. The findings will provide valuable insights for healthcare professionals, policymakers, and researchers in the field of genomics and intensive care medicine.

Key Findings:

• Hope and Relief: Many parents expressed hope and relief upon receiving a diagnosis through rapid genomic sequencing, as it provided clarity and a sense of direction for their child's treatment.
• Emotional Impact: The process of obtaining and interpreting genomic results can be emotionally challenging for parents, requiring significant support and counseling.
• Decision-Making: Parents reported feeling overwhelmed by the decision-making process, especially when faced with complex genomic findings and treatment options.
• Communication and Support: Effective communication between healthcare professionals and parents is crucial. Parents appreciated clear explanations and regular updates, but also noted the need for emotional support during the process.
• Ethical Considerations: Some parents raised concerns about the potential misuse of genomic data and the psychological impact of receiving unexpected findings. They emphasized the importance of informed consent and transparency in the genomic testing process.

Implications and Recommendations:

• Healthcare providers should prioritize emotional support and counseling for parents throughout the genomic sequencing process.
• Clear and transparent communication is essential, ensuring that parents understand the implications of the results and have access to appropriate resources.
• Ethical guidelines and informed consent processes should be regularly reviewed and updated to address the evolving challenges and opportunities in rapid genomic testing.